Showing results (1271-1280 of 9,901) with videos related to
Sort By:
Pageof 991
Bone Marrow Transplantation|September 25, 2012
Intravenous ribavirin for respiratory syncytial viral infections in pediatric hematopoietic SCT recipientsA Molinos-Quintana, C Pérez-de Soto, M Gómez-Rosa, et al.Bone Marrow Transplantation|September 25, 2012
A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplantS K Khaled, J Palmer, T Stiller, et al.Bone Marrow Transplantation|September 25, 2012
Second auto-SCT for treatment of relapsed multiple myelomaW I Gonsalves, M A Gertz, M Q Lacy, et al.Bone Marrow Transplantation|September 25, 2012
Peri-engraftment syndrome in allogeneic hematopoietic SCTK T Hong, H J Kang, N H Kim, et al.Bone Marrow Transplantation|September 25, 2012
Low levels of 25-hydroxyvitamin D before allogeneic hematopoietic SCT correlate with the development of chronic GVHDB Glotzbecker, V T Ho, J Aldridge, et al.Bone Marrow Transplantation|September 4, 2012
Juvenile metachromatic leukodystrophy 10 years post transplant compared with a non-transplanted cohortI Krägeloh-Mann, S Groeschel, C Kehrer, et al.Bone Marrow Transplantation|October 9, 2012
Expression of α4β7 integrin on memory CD8(+) T cells at the presentation of acute intestinal GVHDY-B Chen, S McDonough, H Chen, et al.Bone Marrow Transplantation|October 23, 2012
GVHD after allogeneic haematopoietic SCT for AML: angiogenesis, vascular endothelial growth factor and VEGF receptor expression in the BMM Medinger, A Tichelli, C Bucher, et al.Bone Marrow Transplantation|October 23, 2012
5-day/5-drug myeloablative outpatient regimen for resistant neuroblastomaB H Kushner, S Modak, K Kramer, et al.Bone Marrow Transplantation|August 7, 2012
Biomarkers for acute GVHD: can we predict the unpredictable?Y-B Chen, C S CutlerPageof 991